Table 2.
Weighted average expenditures and standard deviations by type of depression treatment and gender, medicare current beneficiary survey, 2000-2005 a
|
Expenditures |
Antidepressants only |
Psych Tx (with or w/o AD) |
No treatment |
|||||
|---|---|---|---|---|---|---|---|---|
| Mean $ | SD $ | p-value | Mean $ | SD $ | p-value | Mean $ | SD $ | |
|
Total |
17,425 |
18,038.4 |
0.296 |
19,733 |
18,448.7 |
0.005 |
16,795 |
17,956.7 |
|
Inpatient |
5,186 |
9,514.8 |
0.471 |
5,142 |
9,510.3 |
0.604 |
5,473 |
9,546.1 |
|
Outpatient |
1,764 |
3,459.4 |
0.229 |
1,653 |
3,449.8 |
0.859 |
1,617 |
3,447.1 |
|
Medical provider |
4,767 |
4,854.4 |
< 0.001 |
5,839 |
5,130.9 |
< 0.001 |
4,295 |
4,774.9 |
|
Prescription drugs |
2,848 |
1,911.0 |
< 0.001 |
3,076 |
2,001.2 |
< 0.001 |
1,829 |
1,689.9 |
| Other | 2,530 | 9,510.6 | < 0.001 | 3,656 | 9,498.9 | 0.352 | 3,330 | 9,493.8 |
Note: Based on 1,055 elderly community-dwelling Medicare beneficiaries aged 65 years or older, and followed for one year during 2001 through 2005. Expenditures were measured in the follow-up year and depression treatment was measured in year 1. p-values can be used to identify statistically differences in expenditures by depression treatment compared to no depression treatment based on t-tests.
aDue to small number of individuals who received only psychotherapy but no antidepressant treatment, we combined people having psychotherapy with and without antidepressant treatment into one group.
p: p-value; SD: Standard Deviation; Tx: Treatment; AD: Antidepressants; Psych Tx (with or w/o AD): Psychotherapy with or without antidepressants.